Payden & Rygel Investment Group’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-133,500
Closed -$15.2M 123
2024
Q1
$15.2M Buy
+133,500
New +$15.3M 0.72% 49
2023
Q3
$10.9M Buy
+112,590
New +$11.8M 0.74% 62

Other funds holding ABT

Payden & Rygel Investment Group's ABT Position: Q2 2024 in Review

Payden & Rygel Investment Group sold out of Abbott (ABT) in Q2 2024, closing a stake of 133,500 shares — an estimated $15.2M sold.

Payden & Rygel Investment Group first reported a position in ABT in Q3 2023 and held it in 2 quarters. The position peaked at $15.2M in Q1 2024. 2,861 funds tracked by Wall St. Rank hold ABT as of Q2 2024.

  • Payden & Rygel Investment Group reported no remaining Abbott position as of Q2 2024 after selling out during the quarter.
  • Payden & Rygel Investment Group sold 133,500 Abbott shares in Q2 2024, an estimated $15.2M.
  • Payden & Rygel Investment Group first reported a position in Abbott in Q3 2023 and held it in 2 quarters.
  • Payden & Rygel Investment Group's Abbott position peaked at $15.2M in Q1 2024.
  • 2,861 funds tracked by Wall St. Rank held Abbott as of Q2 2024.

Based on Payden & Rygel Investment Group's 13F filing for Q2 2024, filed 12 Aug 2024.